Sharemaestro Newsreel

ElectroCore, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

ElectroCore, Inc. reported its second-quarter and six-month earnings results for the period ended June 30, 2026. For the second quarter, sales increased to $9.45 million from $7.38 million year-over-year, and the net loss narrowed to $3.06 million from $3.67 million. For the six months, …

Standard BioTools (LAB) Stock Rebound Leaves Revenue Slide And Losses In Focus

Standard BioTools (LAB) saw a slight stock rebound after its Q2 2026 earnings, but this is overshadowed by a 7.6% revenue decline to US$20.1 million and persistent losses, despite a narrower net loss from continuing operations. The market is waiting for sustained top-line growth …

QuidelOrtho (Nasdaq: QDEL) trims 2026 revenue and EPS guidance

QuidelOrtho (Nasdaq: QDEL) has reported its second-quarter 2026 results, showing a 2.8% year-over-year revenue increase to $630.9 million but a GAAP net loss of $92.9 million. The company has trimmed its full-year 2026 financial guidance, reducing expected revenue, adjusted EBITDA, and adjusted EPS, and …

Avita Medical upgrades FY26 revenue guidance

Avita Medical announced a reduced statutory net loss of USD7.7 million for the June quarter and updated its full-year 2026 net revenue guidance to between USD86 million and USD89 million, an increase from its previous forecast. The company also anticipates achieving cashflow breakeven in …

Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cerus Corp (CERS) has an earnings forecast score of 8.67, ranking 17th in its industry, with an average analyst price target of $5.00, suggesting a 113.09% upside. Based on 3 analysts, the stock is rated as a "Buy." The company's expected revenue for the …

Profound Medical (NASDAQ: PROF) Q2 loss narrows as revenue rises

Profound Medical Corp. reported a Q2 2026 revenue of $2.5 million, marking a 12% year-over-year increase, with gross margin expanding to 78% and operating expenses falling by 16%. The company's net loss improved by 39% to $9.5 million, or $0.26 per share, and it …

Is Senseonics Holdings Inc (SENS) a Value Trap After Q2 Earnings? Revenue Hits $14.5M with GF Score of 56/100

180 Wealth Advisors LLC Lowers Holdings in Medtronic PLC $MDT

180 Wealth Advisors LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 75% in the second quarter, selling 29,822 shares and retaining 9,951 shares valued at $778,000. Despite this reduction, Medtronic reported strong quarterly results with revenue of $9.81 billion and adjusted EPS …

Balefire LLC Sells 25,744 Shares of Medtronic PLC $MDT

Balefire LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 67.1% in the second quarter, selling 25,744 shares but still retaining 12,614 shares valued at $987,000. Despite this institutional sell-off and recent price target reductions by analysts, Medtronic holds a "Moderate Buy" consensus …

Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026

Lifeward Ltd. (Nasdaq: LFWD) announced it will report its second quarter 2026 financial results on Friday, August 14, 2026. A press release will be issued and a quarterly report filed with the SEC before 9:30 a.m. ET, though no conference call will be held. …

Cytek Biosciences (CTKB) holders report over 7% stakes in Schedule 13G/A

Millennium-affiliated entities and Israel A. Englander have filed an amended Schedule 13G/A, disclosing significant ownership stakes in Cytek Biosciences, Inc. Integrated Core Strategies (US) LLC reported a 5.5% beneficial ownership, while Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported …

Enovis Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:ENOV) 2026-08-07

Tandem Diabetes Care (NASDAQ: TNDM) lifts Q2 sales to $254.6M, trims loss

Tandem Diabetes Care reported strong second-quarter 2026 results, with worldwide sales increasing by 6% to $254.6 million and a significant improvement in gross margin to 57%. The company also narrowed its GAAP net loss to $21.2 million and achieved positive Adjusted EBITDA of $6.4 …

The Manufacturers Life Insurance Company Sells 65,658 Shares of Penumbra, Inc. $PEN

The Manufacturers Life Insurance Company significantly reduced its stake in Penumbra, Inc. by selling 65,658 shares, now holding 20,047 shares valued at $6.6 million. Despite collective institutional ownership of 88.88%, analyst sentiment for Penumbra is mixed with a "Hold" consensus and a target price …

PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class Action - Contact SueWallSt

This article announces a lead plaintiff deadline of August 31, 2026, for a securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that Insulet made misleading statements regarding its manufacturing quality after two voluntary medical device corrections led to significant drops …

Pacific Biosciences of California, Inc. Stock 12‑Month Price Target Cut to $2.29, Implies 76% Upside

The average 12-month price target for Pacific Biosciences of California, Inc. (PACB) stock has been lowered from $2.46 to $2.29 by 6 analysts, suggesting a potential upside of approximately 76% from its August 5th closing price. Despite the target cut, the consensus rating from …

Amundi Increases Stock Position in Bruker Corporation $BRKR

Amundi increased its stake in Bruker Corporation (NASDAQ:BRKR) by 244.2% in the first quarter, now holding 62,611 shares valued at $2.26 million. Despite the company beating EPS estimates for Q2 2026 with $0.49 per share, its revenue of $838.5 million missed analyst expectations, raising …

DexCom Inc. Stock Sheds 4.9%, Underperforms Market

The article reports that DexCom Inc. (DXCM) stock experienced a 4.9% decline, leading to its underperformance in the market. The brief notice, sourced from Dow Jones, indicates a negative movement for the company's shares. Further details require a user to log in.

About 40% of Treace’s Lapiplasty surgeon users use new systems

Treace Medical Concepts reported a 4% decline in Q2 2026 revenue to $45.4 million year-over-year, alongside a net loss of $15.9 million. Despite the revenue dip, the company saw an 8% reduction in operating expenses and significantly decreased year-to-date cash usage by 57%. Treace …

Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump

RxSight (RXST) Stock Faces Margin Strain After Guidance Withdrawal

Sanuwave Health (SNWV) to Release Quarterly Earnings on Friday

Smith & Nephew Earnings: Weakness in First Half Could Linger in Second Half

Artivion Q2 Earnings Call Highlights

Key Points Interested in Artivion, Inc.? Here are five stocks we like better. Artivion's Q2 revenue rose 9% to $125.8 million on a constant-currency basis, driven by 12% growth in stent grafts and 18% growth in On-X valves. Adjusted EBITDA increased 7% to $26.4 …

Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD)

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Establishment Labs (NASDAQ:ESTA) Stock

RXST|Rxsight Inc|Price:6.260|Chg%:+0.180

Steris Earnings: Healthy Fundamentals Allow for Accelerated Repurchases and More Investment

STERIS (STE) Stock Looks Near Fair Value After $600 Million Expansion

Butterfly Network (BFLY) Could Be 18% Overvalued Following Raised Guidance And Earnings Beat

Edwards Lifesciences Corporation (NYSE:EW) Given Consensus Rating of "Moderate Buy" by Analysts

Edwards Lifesciences (NYSE:EW) has received a "Moderate Buy" consensus rating from 23 brokerages, with an average 12-month price target of $100.27, exceeding its current share price of $89.33. The company recently surpassed earnings and revenue expectations, reporting $0.78 EPS on $1.74 billion revenue, and …

Orthofix Medical (OFIX) Stock Sinks As One Off Growth Clouds Outlook

Orthofix Medical's stock dropped 15% despite management raising full-year revenue and adjusted EBITDA guidance. While the company showed progress in profitability and growth in specific product areas, concerns remain regarding the quality and concentration of its revenue, including a one-off European distributor purchase that …

InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for InspireMD Inc (NSPR), detailing its current earnings forecast score, average price target from analysts, and a comparison with peers. It highlights expected revenue, EPS for past and upcoming quarters, and the overall analyst rating, which leans towards …

HAEMONETICS CORP 2026: Revenue $339.38M, EPS $0.72— 10-Q Summary

HAEMONETICS CORP reported strong financial results for the 2026 quarter, with revenue increasing by 5.6% year-over-year to $339.38 million. Diluted EPS also saw a rise to $0.72. The company attributed its revenue growth to expanded Apheresis plasma volume and market share gains in its …

Lost Money on Inspire Medical Systems, Inc. (INSP)? Urged to Join

Levi & Korsinsky LLP has filed a class action securities lawsuit against Inspire Medical Systems, Inc. (NYSE:INSP) on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025. The lawsuit alleges that Inspire Medical Systems made false statements and concealed …

Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside

RxSight Inc (NASDAQ:RXST) is scheduled to release its Q2 2026 earnings on August 7, 2026, with revenue expected at $32.55 million and earnings at $-0.32 per share. GuruFocus estimates a significant upside of 518.60% for RXST based on its GF Value of $38.91, despite …